We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$416B
AUM Growth
+$4.09B
Cap. Flow
+$6.05B
Cap. Flow %
1.45%
Top 10 Hldgs %
16.07%
Holding
3,410
New
61
Increased
1,883
Reduced
1,273
Closed
71

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$462M
2
NVDA icon
NVIDIA
NVDA
+$385M
3
META icon
Meta Platforms (Facebook)
META
+$311M
4
AAPL icon
Apple
AAPL
+$301M
5
EXE
Expand Energy Corp
EXE
+$294M

Sector Composition

Rank Sector Weight
1 Technology 20.43%
2 Financials 18.32%
3 Industrials 12.44%
4 Consumer Discretionary 10.89%
5 Healthcare 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
3326
Lineage Cell Therapeutics
LCTX
$262M
$20.3K ﹤0.01%
40,449
AYTU icon
3327
AYTU BioPharma
AYTU
$22.8M
$18.2K ﹤0.01%
10,926
-10,906
-50% -$19.9K
RPTX
3328
DELISTED
Repare Therapeutics
RPTX
$17.4K ﹤0.01%
13,265
SY
3329
So-Young International
SY
$199M
$16.2K ﹤0.01%
19,737
CMPX icon
3330
Compass Therapeutics
CMPX
$362M
$16.1K ﹤0.01%
11,117
REI icon
3331
Ring Energy
REI
$287M
$15.5K ﹤0.01%
11,409
-10,248
-47% -$15.4K
NDLS icon
3332
Noodles & Co
NDLS
$84.8M
$15.3K ﹤0.01%
3,313
-15,262
-82% -$112K
PRLD icon
3333
Prelude Therapeutics
PRLD
$349M
$13.9K ﹤0.01%
10,981
-18,101
-62% -$24K
SPRO icon
3334
Spero Therapeutics
SPRO
$70.1M
$10.3K ﹤0.01%
10,003
PED icon
3335
PEDEVCO
PED
$154M
$9.88K ﹤0.01%
635
VFF icon
3336
Village Farms International
VFF
$246M
$9.54K ﹤0.01%
12,380
LYEL icon
3337
Lyell Immunopharma
LYEL
$316M
$8.62K ﹤0.01%
673
-157
-19% -$3.11K
IVVD icon
3338
Invivyd
IVVD
$176M
$7.71K ﹤0.01%
17,327
RLMD icon
3339
Relmada Therapeutics
RLMD
$539M
$7.5K ﹤0.01%
14,428
-58,976
-80% -$144K
AFRI icon
3340
Forafric Global
AFRI
$290M
-11,879
Closed -$135K
AHT
3341
Ashford Hospitality Trust
AHT
$20.9M
-2,691
Closed -$20.1K
LONA
3342
LeonaBio Inc
LONA
$66.3M
-32,145
Closed -$143K
JBIO
3343
Jade Biosciences
JBIO
$1.14B
-302
Closed -$22.1K
CMCT
3344
Creative Media & Community Trust
CMCT
$8.25M
-3
Closed -$34.5K
CODX
3345
Co-Diagnostics
CODX
$6.97M
-351
Closed -$13.2K
CPSH icon
3346
CPS Technologies
CPSH
$71.9M
-16,637
Closed -$23.6K
CRNX icon
3347
Crinetics Pharmaceuticals
CRNX
$8.88B
-392,196
Closed -$20M
CUE icon
3348
Cue Biopharma
CUE
$131M
-486
Closed -$10.9K
CVM icon
3349
CEL-SCI Corp
CVM
$21.1M
-549
Closed -$17.5K
DCOR icon
3350
Dimensional US Core Equity 1 ETF
DCOR
$3.32B
-60,000
Closed -$3.8M

Similar funds

Dimensional Fund Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
  • Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
  • Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
  • Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
  • Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
  • Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
  • Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.